Paul Ullom-minnich MD in Moundridge, Kansas

Medical School: University Of Kansas School Of Med (kc/wich/sal)
Graduation Year: 1996
The Primary Medical Specialty for Paul Ullom-minnich MD is listed as: Family Practice
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 28
PAC (PECOS ID)#: 2163460775
NPI #: 1326043241
NPI Created On: 06/16/2005
NPI Last Updated Listed as: 07/09/2007
Primary Taxonomy Code: 207Q00000X
License Number:
0425280
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Medica Insurance Company
• Humana
• Blue Cross Blue Shield
• Sunflower State Health Plan, Inc
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

---

Services and Procedures include:

1. Destruction of skin growth
2. Destruction of 2-14 skin growths
3. Aspiration and/or injection of large joint or joint capsule
4. Insertion of needle into vein for collection of blood sample
5. Ct scan head or brain
6. X-ray of chest, 2 views
7. X-ray of chest, 2 views
8. Blood test, lipids (cholesterol and triglycerides)
9. Urinalysis, manual test
10. Hemoglobin a1c level
11. Blood test, clotting time
12. Vaccine for influenza for administration into muscle, 0.5 ml dosage
13. Pure tone air conduction threshold hearing assessment
14. Routine ekg using at least 12 leads including interpretation and report
15. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
16. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
17. Established patient office or other outpatient visit, typically 10 minutes
18. Established patient office or other outpatient visit, typically 15 minutes
19. Established patient office or other outpatient, visit typically 25 minutes
20. Established patient office or other outpatient, visit typically 40 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.